Aurora Cannabis Inc.
corporate_fare Company Profile
Aurora Cannabis Inc. (NASDAQ:ACB) is a publicly traded company in the Life Sciences sector. Wiseek monitors ACB SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Aurora Cannabis Flags Fresh Internal Control Weakness Over Biological Assets and Inventory
- Aurora Cannabis Reports Record Annual Medical Revenue & EBITDA, but Forecasts FY27 Revenue Decline and Lower EBITDA
- Aurora Cannabis Reports Record Annual Revenue and EBITDA, Medical Cannabis Sales Up 18%
- Aurora Cannabis Reports Material Weakness in Internal Controls, Posts Significant Annual Loss, and Details Strategic Shifts
- Aurora Secures Plant Breeders' Rights for Two Proprietary Cannabis Cultivars in Canada
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for ACB, detected from its recent SEC filings · based on capital-structure filings through 2026-02-04.
Finalizes $100 Million ATM Program · Significant Potential Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
ACB files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.